BIOGEN INC.: operating lease liability

What this measure means

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Exact concept: us-gaap:OperatingLeaseLiability. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2019-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• BIOGEN INC.: total assets
• BIOGEN INC.: total liabilities
• BIOGEN INC.: stockholders equity
• BIOGEN INC.: cash and cash equivalents
• BIOGEN INC.: net income or loss
• BIOGEN INC.: operating cash flow
• BIOGEN INC.: capital expenditure payments
• BIOGEN INC.: revenue
• BIOGEN INC.: financing cash flow
• BIOGEN INC.: investing cash flow
• BIOGEN INC.: retained earnings or deficit
• BIOGEN INC.: basic weighted-average shares
• BIOGEN INC.: diluted weighted-average shares
• BIOGEN INC.: basic earnings per share
• BIOGEN INC.: diluted earnings per share
• BIOGEN INC.: income tax expense or benefit
• BIOGEN INC.: net property, plant and equipment
• BIOGEN INC.: share-based compensation expense
• BIOGEN INC.: operating income or loss
• BIOGEN INC.: current assets
• BIOGEN INC.: interest expense
• BIOGEN INC.: current liabilities
• BIOGEN INC.: current accounts payable
• BIOGEN INC.: goodwill carrying amount
• BIOGEN INC.: net finite-lived intangible assets
• BIOGEN INC.: net current accounts receivable
• BIOGEN INC.: common-stock repurchase payments
• BIOGEN INC.: net inventory
• BIOGEN INC.: gross profit
• BIOGEN INC.: cost of revenue
• BIOGEN INC.: selling, general and administrative expense
• BIOGEN INC.: research and development expense
• BIOGEN INC.: common shares outstanding
• BIOGEN INC.: cash including restricted cash
• BIOGEN INC.: additional paid-in capital
• BIOGEN INC.: accumulated other comprehensive income or loss
• BIOGEN INC.: total equity including noncontrolling interests
• BIOGEN INC.: operating lease right-of-use asset
• BIOGEN INC.: long-term debt
• BIOGEN INC.: gross property, plant and equipment
• BIOGEN INC.: accumulated depreciation on property, plant and equipment
• BIOGEN INC.: net intangible assets excluding goodwill
• BIOGEN INC.: other noncurrent assets
• BIOGEN INC.: other noncurrent liabilities
• BIOGEN INC.: net deferred tax assets
• BIOGEN INC.: net deferred tax liabilities
• BIOGEN INC.: pre-tax income or loss from continuing operations
• BIOGEN INC.: profit or loss including noncontrolling interests
• BIOGEN INC.: comprehensive income or loss
• BIOGEN INC.: net income available to common stockholders
• BIOGEN INC.: depreciation expense
• BIOGEN INC.: depreciation, depletion and amortization
• BIOGEN INC.: amortization of intangible assets
• BIOGEN INC.: other nonoperating income or expense
• BIOGEN INC.: nonoperating income or expense
• BIOGEN INC.: current income tax expense or benefit
• BIOGEN INC.: deferred income tax expense or benefit
• BIOGEN INC.: interest paid, net
• BIOGEN INC.: income taxes paid, net
• BIOGEN INC.: operating lease payments
• BIOGEN INC.: change in accounts receivable
• BIOGEN INC.: change in inventories

Inspect the source

Entity

BIOGEN INC. / CIK 0000875045

Captured

2026-09-20T05:00:52.520Z

SEC response SHA-256

e49b5a3bbf14de0fb7d239cc7824bd2fd0df6e7d76ccea2ef08421f0f26763e0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000875045.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))